Academia and industry: lessons from the unfortunate events in Toronto

Lancet. 1999 Mar 6;353(9155):771-2. doi: 10.1016/s0140-6736(99)00072-0.
No abstract available

MeSH terms

  • Academic Medical Centers* / legislation & jurisprudence
  • Academic Medical Centers* / trends
  • Clinical Trials as Topic / legislation & jurisprudence
  • Deferiprone
  • Drug Industry* / legislation & jurisprudence
  • Drug Industry* / trends
  • Humans
  • Iron Chelating Agents / therapeutic use
  • Ontario
  • Pyridones / therapeutic use
  • Thalassemia / drug therapy

Substances

  • Iron Chelating Agents
  • Pyridones
  • Deferiprone